Patent · US Expired

Methods and compositions for obtaining mature dendritic cells

US6274378A · kind A · utility

68Cited by
4References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 27, 1998
Grant dateAug 14, 2001
Priority date
Expiry dateOct 27, 2018

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2501/25
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

We describe an improved method for generating sizable numbers of mature dendritic cells from nonproliferating progenitors in human blood. The first step or "priming" phase is a culture of T cell depleted mononuclear cells in medium supplemented with GM-CSF and IL-4 to produce immature dendritic cells. The second step or "differentiation" phase requires the exposure to dendritic cell maturation factor such as monocyte conditioned medium. Using this two-step approach, substantial yields are obtained. The dendritic cells derive from this method have all the features of mature cells. They include a stellate cell shape, nonadherence to plastic, and very strong T cell stimulatory activity. The mature dendritic cells produced according to this invention are useful for activating T cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.